Amani Therapeutics, Inc.

New Filing
CIK: 0002099941·Other Health Care·DELAWARE·Filed: Oct 1, 2026
Total Offering

$59,999,999

Amount Sold

$34,999,999

Investors

5

First Sale

Sep 16, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2025
Non-Accredited Investors
No

Related Persons

NameRole
Alice Lee
Related Person
-- RTW Holdings VI, LLC
Related Person
Robert Swoboda
Related Person
Lauren Cuje
Related Person
Peter Fong
Related Person
Connor Williams
Related Person

Company

Amani Therapeutics, Inc.

40 10TH AVENUE

NEW YORK, NY, 10014

(646) 597-6980

SEC Filing

0002099941-26-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free